Showing results (271-280 of 472) with videos related to
Sort By:
Pageof 48
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cellsC Billard, F Sigaux, S Castaigne, et al.Journal of Chromatography. B, Biomedical Applications|April 7, 1995
Simultaneous determination of all-trans and 13-cis retinoic acids and their 4-oxo metabolites by adsorption liquid chromatography after solid-phase extractionP Lefebvre, A Agadir, M Cornic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationshipA Agadir, M Cornic, P Lefebvre, et al.Leukemia|December 1, 1991
Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemiaP Lefebvre, G Thomas, B Gourmel, et al.Blood|June 1, 1978
Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet functionS Levy-Toledano, G Tobelem, C Legrand, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Typing for HLA DQ using oligonucleotidic probesI Khalil, L d'Auriol, L Morin, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cellsA Bensussan, J F Lagabrielle, S Castaigne, et al.The Journal of Clinical Investigation|September 1, 1988
Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantationE Vilmer, P Guglielmi, V David, et al.Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatmentG Flandrin, F Sigaux, S Castaigne, et al.Clinical Transplantation|November 15, 1997
Evaluation of neurotoxicity in pediatric renal transplant recipients treated with tacrolimus (FK506)A M Neu, S L Furth, B W Case, et al.Pageof 48